Found this link on the company website.
The author is the same analyst who first covered US-based Celator Pharma Inc.
Calator had a new drug for leukemia in development when it was acquired by Jazz Pharma for $US 1.5 billion cash in 2016.
https://hcwco.bluematrix.com/sellside/EmailDocViewer?encrypt=56386c96-fe8c-448f-bbef-96012ab56fcd&mime=pdf&co=Hcwco&[email protected]&source=mail
- Forums
- ASX - By Stock
- PTX
- new research note from US analyst
new research note from US analyst
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
0.001(1.30%) |
Mkt cap ! $31.40M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.7¢ | $23.65K | 615.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 564695 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 26186 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 564695 | 0.038 |
10 | 616067 | 0.037 |
8 | 688946 | 0.036 |
7 | 571733 | 0.035 |
1 | 40000 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 26186 | 2 |
0.042 | 200000 | 1 |
0.044 | 286522 | 2 |
0.045 | 509634 | 5 |
0.046 | 298002 | 2 |
Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online